Combined tDCS and Cognitive Training as an Adjunctive Treatment in Opioid Use Disorder

Combined tDCS and Cognitive Training as an Adjunctive Treatment in Opioid Use Disorder

The overall goal of this study is to investigate the added benefit of a neuromodulation intervention in individuals taking medication for treatment for Opioid Use Disorder(OUD).

Inclusion Criteria:

• Ability to provide consent and comply with study procedures
• Diagnostic and Statistical Manual of Mental Disorders criteria for OUD
• Undergoing medication treatment for OUD. Participants may have current comorbid drug use, but primary diagnosis must be OUD
• Intention to remain in the study until intervention completion.

Exclusion Criteria:

• Any medical condition with neurological sequelae
• Head injury resulting in skull fracture or loss of consciousness of >30 minutes
• Any tDCS or MRI contraindication (tDCS: history of seizures, metallic cranial plates/screws or implanted device, history of eczema on scalp. MRI: unapproved metallic implants, pacemakers or any other implanted electrical device, shrapnel, metallic braces, non-removable body piercings, pregnancy, breathing or movement disorder, or claustrophobia)
• Any psychotic disorder (participants with other treated and stable psychiatric disorders will be included)
• Presence of a condition that would render study measures impossible to administer or interpret
• Age younger than 18
• Primary current substance use disorder on a substance other than opioids except for caffeine or nicotine
• In treatment instead of jail
• Pregnancy
• Disrespectful behavior towards the investigators and staff.